2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
43
Neoplasms
24
Motor Activity
12
Pain, Postoperative
9
Colorectal Neoplasms
9
Stomach Neoplasms
8
Lung Neoplasms
8
Fatigue
7
Anxiety Disorders
6
Pain
5
Carcinoma, Hepatocellular
5
Rectal Neoplasms
4
Polycystic Ovary Syndrome
4
Leukemia, Myeloid, Acute
4
Depression
4
Colonic Neoplasms
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Sleep Initiation and Maintenance Disorders
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Malnutrition
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Agnosia
3
Vomiting
2
Urinary Incontinence
2
Interventions
Folfox protocol
2
Bevacizumab
2
pembrolizumab
1
IFL protocol
1
HMPL-013
1
Drug Therapy
1
Control Groups
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unresectable Metastatic Colorectal Cancer
×
Control Groups
×
Clear all
NCT06642844
2024-10-15
PHARBEVACOL
University Hospital, Tours
Phase 3
Not yet recruiting
244 enrolled